Odonate Therapeutics Inc. Stock News

Odonate Therapeutics Inc (ODT) shares closed today 16.8% lower than it did at the end of yesterday. The stock is currently down 19.3% year-to-date, down 94.5% over the past 12 months, and down 95.3% over the past five years. Today, the Dow Jones Industrial Average fell 0.0%, and the S&P 500 fell 0.4%. Trading Activity Shares traded as high as $1.56 and as low as $0.85 this week.Shares closed 96.2% below its 52-week high and 28.2% above its 52-week low.Trading volume this week was 89.0% lower than the 10-day average and 86.2% lower than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.3. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price lags the S&P 500 Index today, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price lags the Dow Jones Industrial Average today, lags it on a 1-year basis, and lags it on a 5-year basis The company share price lags the performance of its peers in the Health Care industry sector today, lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -1296.8% The company's stock price performance over the past 12 months lags the peer average by 14859.9% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

The stock price of Odonate Therapeutics Inc (NASDAQ: ODT) fell by over 17% during intraday trading today. This is why it happened.

Odonate Therapeutics Inc (ODT) shares closed today at 0.8% above its 52 week low of $1.30, giving the company a market cap of $50M. The stock is currently down 3.0% year-to-date, down 93.1% over the past 12 months, and down 94.3% over the past five years. This week, the Dow Jones Industrial Average fell 0.5%, and the S&P 500 fell 1.7%. Trading Activity Trading volume this week was 61.2% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.3. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -655.2% The company's stock price performance over the past 12 months lags the peer average by 5661.3% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

SAN DIEGO, Dec. 22, 2021 (GLOBE NEWSWIRE) -- National law firm Morris Kandinov is investigating the actions of the officers and board of directors of Corcept Therapeutics, Inc., Match Group, Inc., Inc., loanDepot, Inc., and Odonate Therapeutics, Inc. If you are a current owner of shares of any of these stocks, contact [email protected] or call (619) 780-3993.

Odonate Therapeutics, Inc. (NASDAQ:ODT) was the target of a large growth in short interest in November. As of November 30th, there was short interest totalling 513,400 shares, a growth of 85.0% from the November 15th total of 277,500 shares. Based on an average trading volume of 604,900 shares, the short-interest ratio is currently 0.8 days. []

Odonate Therapeutics, Inc. (NASDAQ:ODT) major shareholder Ecor1 Capital, Llc purchased 185,941 shares of the companys stock in a transaction dated Wednesday, December 1st. The stock was purchased at an average price of $1.66 per share, for a total transaction of $308,662.06. The transaction was disclosed in a document filed with the Securities & Exchange Commission, []

Assenagon Asset Management S.A. raised its holdings in shares of Odonate Therapeutics, Inc. (NASDAQ:ODT) by 543.1% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 346,296 shares of the companys stock after acquiring an additional 292,452 shares during the quarter. Assenagon Asset Management []

Odonate Therapeutics, Inc. (NASDAQ:ODT) major shareholder Ecor1 Capital, Llc bought 185,941 shares of Odonate Therapeutics stock in a transaction that occurred on Wednesday, December 1st. The stock was bought at an average price of $1.66 per share, for a total transaction of $308,662.06. The purchase was disclosed in a legal filing with the Securities & []

State Street Corp cut its position in Odonate Therapeutics, Inc. (NASDAQ:ODT) by 67.2% in the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 125,138 shares of the companys stock after selling 255,980 shares during the quarter. State Street Corps holdings in Odonate Therapeutics were worth $437,000 as of its most recent SEC filing. Several other []

Marshall Wace North America L.P. acquired a new position in shares of Odonate Therapeutics, Inc. (NASDAQ:ODT) in the 2nd quarter, Holdings Channel.com reports. The fund acquired 39,890 shares of the companys stock, valued at approximately $139,000. Other institutional investors and hedge funds also recently modified their holdings of the company. Susquehanna Fundamental Investments LLC purchased []

Odonate Therapeutics, Inc. (NASDAQ:ODT) major shareholder Boxer Capital, Llc sold 200,000 shares of the companys stock in a transaction on Wednesday, November 24th. The stock was sold at an average price of $1.57, for a total transaction of $314,000.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible []

Odonate Therapeutics, Inc. (NASDAQ:ODT) major shareholder Boxer Capital, Llc sold 200,000 shares of the stock in a transaction dated Wednesday, November 24th. The shares were sold at an average price of $1.57, for a total value of $314,000.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at []

Odonate Therapeutics, Inc. (NASDAQ:ODT) major shareholder Boxer Capital, Llc sold 200,000 shares of the businesss stock in a transaction that occurred on Monday, November 22nd. The shares were sold at an average price of $1.55, for a total value of $310,000.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which []

Walleye Trading LLC decreased its position in shares of Odonate Therapeutics, Inc. (NASDAQ:ODT) by 72.0% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 21,809 shares of the companys stock after selling 55,975 shares during the quarter. Walleye Trading LLC owned 0.06% of []

Odonate Therapeutics, Inc. (ODT) with the stream of -7.65% also noticed, India Tarena International, Inc. (TEDU) encountered a rapid change of -2.32% in the last hour of Monday’s trading session. … The post Trending Stock to Observe: Odonate Therapeutics, Inc. (NASDAQ:ODT), Tarena International, Inc. (NASDAQ:TEDU) appeared first on Stocks Equity .